Pirfenidone for idiopathic pulmonary fibrosis

被引：63
作者：
Bouros, Demosthenes [1 ]
机构：
[1] Democritus Univ Thrace, Sch Med, Dept Pneumonol, Alexandroupolis 68100, Greece
来源：
LANCET | 2011年 / 377卷 / 9779期
关键词：
D O I：
10.1016/S0140-6736(11)60546-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1727 / 1729
页数：3
相关论文
共 12 条
  • [1] Current and future therapeutic approaches in idiopathic pulmonary fibrosis
    Bouros, D
    Antoniou, KM
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (04) : 693 - 702
  • [2] Interferon gamma for idiopathic pulmonary fibrosis
    Bouros, Demosthenes
    [J]. LANCET, 2009, 374 (9685) : 180 - 182
  • [3] Idiopathic pulmonary fibrosis and pirfenidone
    Collard, H. R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (04) : 728 - 729
  • [4] du Bois RM, 2011, AM J RESP CRIT CARE, V183, P1231, DOI [10.1164/rccm.201007-1179OC, 10.1164/rccm.201007.1179OC]
  • [5] Epidemiology of interstitial lung diseases in Greece
    Karakatsani, A.
    Papakosta, D.
    Rapti, A.
    Antoniou, K. M.
    Dimadi, M.
    Markopoulou, A.
    Latsi, P.
    Polychronopoulos, V.
    Birba, G.
    Ch, Labrakis
    Bouros, D.
    [J]. RESPIRATORY MEDICINE, 2009, 103 (08) : 1122 - 1129
  • [6] Fibrotic idiopathic interstitial pneumonia - The prognostic value of longitudinal functional trends
    Latsi, PI
    du Bois, RM
    Nicholson, AG
    Colby, TV
    Bisirtzoglou, D
    Nikolakopoulou, A
    Veeraraghavan, S
    Hansell, DM
    Wells, AU
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) : 531 - 537
  • [7] The clinical course of patients with idiopathic pulmonary fibrosis
    Martinez, FJ
    Safrin, S
    Weycker, D
    Starko, KM
    Bradford, WZ
    King, TE
    Flaherty, KR
    Schwartz, DA
    Noble, PW
    Raghu, G
    Brown, KK
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) : 963 - 967
  • [8] Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
    Noble, Paul W.
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    Glassberg, Marilyn K.
    Kardatzke, David
    King, Talmadge E., Jr.
    Lancaster, Lisa
    Sahn, Steven A.
    Szwarcberg, Javier
    Valeyre, Dominique
    du Bois, Roland M.
    [J]. LANCET, 2011, 377 (9779) : 1760 - 1769
  • [9] Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone - Results of a prospective, open-label phase II study
    Raghu, G
    Johnson, WC
    Lockhart, D
    Mageto, Y
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (04) : 1061 - 1069
  • [10] An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
    Raghu, Ganesh
    Collard, Harold R.
    Egan, Jim J.
    Martinez, Fernando J.
    Behr, Juergen
    Brown, Kevin K.
    Colby, Thomas V.
    Cordier, Jean-Francois
    Flaherty, Kevin R.
    Lasky, Joseph A.
    Lynch, David A.
    Ryu, Jay H.
    Swigris, Jeffrey J.
    Wells, Athol U.
    Ancochea, Julio
    Bouros, Demosthenes
    Carvalho, Carlos
    Costabel, Ulrich
    Ebina, Masahito
    Hansell, David M.
    Johkoh, Takeshi
    Kim, Dong Soon
    King, Talmadge E., Jr.
    Kondoh, Yasuhiro
    Myers, Jeffrey
    Mueller, Nestor L.
    Nicholson, Andrew G.
    Richeldi, Luca
    Selman, Moises
    Dudden, Rosalind F.
    Griss, Barbara S.
    Protzko, Shandra L.
    Schuenemann, Holger J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (06) : 788 - 824
12